Life Biosciences

The AI engine Fit Assessment

Beta

Life Biosciences develops innovative drug therapies aimed at addressing age-related diseases and promoting healthier aging. Their research focuses on targeting biological mechanisms that contribute to the aging process.

Blurb

Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.

HQ Location

Boston (United States)

Founded

2017

Employees

11 - 50

Total funding raised

$206.77M

Funding Status

Series C, $82.00M, January 5, 2022

Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical

unmet needs.